volume 94 issue 3 pages 973-983

Total Synthesis of Talatisamine: Exploration of Convergent Synthetic Strategies

Publication typeJournal Article
Publication date2021-01-13
scimago Q2
wos Q2
SJR0.678
CiteScore7.0
Impact factor3.8
ISSN00092673, 13480634
General Chemistry
Abstract

Talatisamine (1) is a highly oxygenated C19-diterpenoid alkaloid with K+ channel inhibitory, antiarrhythmic, and neuroprotective activities. Its intricately fused 6/7/5/6/6/5-membered hexacyclic structure (ABCDEF-ring) possesses one nitrogen functionality, five oxygen functionalities, and 12 contiguously aligned stereocenters. This account describes the development of convergent strategies to efficiently assemble this synthetically challenging natural product. First, we explored two radical-based strategies. Treatment of the AE-ring with Et3B and O2 generated a highly reactive C11-bridgehead radical, which sequentially added to the C-ring and the aldehyde via a radical-polar crossover mechanism to afford ACE-ring substructure 6 in a single step. Alternatively, after coupling of the AE-ring and C-ring, the C11-bridgehead radical was utilized to cyclize the central 7-membered B-ring. The 6-membered D-ring was then forged by selenium-induced 6-endo cyclization to furnish ABCDE-ring 3. Second, we pursued a skeletal rearrangement strategy, which culminated in the total synthesis of 1. The D-ring was coupled with the AE-ring as the aromatic ring. Oxidative dearomatization, followed by Diels-Alder reaction, led to the 6/6-membered ring system, which was transformed into the 7/5-membered BC-ring through a stereospecific Wagner-Meerwein rearrangement. Finally, Hg(OAc)2 induced an oxidative aza-Prins cyclization to form the remaining 5-membered F-ring, thereby completing the chemical construction of 1.

Found 
Found 

Top-30

Journals

1
Journal of the American Chemical Society
1 publication, 20%
Tetrahedron Letters
1 publication, 20%
Tetrahedron
1 publication, 20%
Chemical Communications
1 publication, 20%
RSC Advances
1 publication, 20%
1

Publishers

1
2
Elsevier
2 publications, 40%
Royal Society of Chemistry (RSC)
2 publications, 40%
American Chemical Society (ACS)
1 publication, 20%
1
2
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
5
Share
Cite this
GOST |
Cite this
GOST Copy
SHIMAKAWA T., Hagiwara K., Inoue M. Total Synthesis of Talatisamine: Exploration of Convergent Synthetic Strategies // Bulletin of the Chemical Society of Japan. 2021. Vol. 94. No. 3. pp. 973-983.
GOST all authors (up to 50) Copy
SHIMAKAWA T., Hagiwara K., Inoue M. Total Synthesis of Talatisamine: Exploration of Convergent Synthetic Strategies // Bulletin of the Chemical Society of Japan. 2021. Vol. 94. No. 3. pp. 973-983.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1246/bcsj.20200400
UR - https://academic.oup.com/bcsj/article/94/3/973/7334744
TI - Total Synthesis of Talatisamine: Exploration of Convergent Synthetic Strategies
T2 - Bulletin of the Chemical Society of Japan
AU - SHIMAKAWA, Tsukasa
AU - Hagiwara, Koichi
AU - Inoue, Masayuki
PY - 2021
DA - 2021/01/13
PB - Oxford University Press
SP - 973-983
IS - 3
VL - 94
SN - 0009-2673
SN - 1348-0634
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2021_SHIMAKAWA,
author = {Tsukasa SHIMAKAWA and Koichi Hagiwara and Masayuki Inoue},
title = {Total Synthesis of Talatisamine: Exploration of Convergent Synthetic Strategies},
journal = {Bulletin of the Chemical Society of Japan},
year = {2021},
volume = {94},
publisher = {Oxford University Press},
month = {jan},
url = {https://academic.oup.com/bcsj/article/94/3/973/7334744},
number = {3},
pages = {973--983},
doi = {10.1246/bcsj.20200400}
}
MLA
Cite this
MLA Copy
SHIMAKAWA, Tsukasa, et al. “Total Synthesis of Talatisamine: Exploration of Convergent Synthetic Strategies.” Bulletin of the Chemical Society of Japan, vol. 94, no. 3, Jan. 2021, pp. 973-983. https://academic.oup.com/bcsj/article/94/3/973/7334744.